Por: Forbes Tech January 11, 2023
InnovationRx is your weekly digest of healthcare news. To get it in your inbox, . getty that it’s reducing its headcount by 20% and restructuring its clinical priorities. Its current CSO, Mark Shearman, will be departing the company. The company says this prioritization will give it a cash runway through 2025. Meanwhile, vaccine companies and both announced that they’re getting new CEOs, John C. Jacobs and Alexander Zehnder. There have also... + full article
Fox Business USA Business January 07, 2023
Check out what's clicking on FoxBusiness.com An Alzheimer’s drug from has received accelerated approval from the Food and Drug Administration (FDA), the companies and agency announced Friday. Lecanemab appeared to reduce brain amyloid plaque — a marker of... + más
Biogen Stock: How Biogen Makes Money In 2022 And How They Defied Gravity | Forbes
FDA approves Alzheimer's drug that slowed cognitive decline in clinical trial | CNBC
CNBC USA Health January 06, 2023
In this articleMRI image of brain showing area of Alzheimer patient.Getty ImagesThe Food and Drug Administration on Friday granted accelerated approval for the Alzheimer's drug lecanemab, the second treatment from and its Japanese partner Eisai to receive an early green... + más
Reimagining Alzheimer’s (Part 4): Cautious Optimism For A New Alzheimer’s Disease Treatment | Forbes
FDA Approves Alzheimer's Drug That Slowed Cognitive Decline in Clinical Trial | NBC 6 South Florida
NBC 6 South Florida USA World January 06, 2023
Getty Images MRI image of brain showing area of Alzheimer patient. data-ellipsis=false> The Food and Drug Administration on Friday granted accelerated approval for the Alzheimer's drug lecanemab, the second treatment from and its Japanese partner Eisai to receive an early... + más
The Advocate USA Health January 02, 2023
What is Alzheimer’s disease?German neurologist Dr. Alois Alzheimer first identified this neurological disorder in 1906 while studying the pathology of a woman he had treated for an unusual mental illness.While examining her brain after her death, Alzheimer noticed marked... + más
How To Spot The Early Signs Of Alzheimer's | Newsweek
WPLG Local 10 USA Politics December 30, 2022
WASHINGTON – The Food and Drug Administration’s contentious approval of a questionable Alzheimer’s drug took another hit Thursday as congressional investigators called the process “rife with irregularities.”The 18-month investigation by two House committees detailed... + más
Alzheimer's drug trial shown to slow cognitive decline in long fight against dementia | CNBC
Los Angeles Times USA Science December 30, 2022
The Food and Drug Administration’s contentious approval of a questionable Alzheimer’s drug took another hit Thursday as congressional investigators called the process “rife with irregularities.” The 18-month investigation by two House committees detailed “atypical... + más
Probe: Alzheimer's drug approval 'rife with irregularities' | ABC News
Probe: Alzheimer's drug approval 'rife with irregularities' | WPLG Local 10
Time USA Health December 01, 2022
Over the past few years, Alzheimer’s patients and their caregivers have been on a roller-coaster ride full of highs and lows in the search for treatments—and new research presents another emotionally thrilling loop. In data presented at the annual in San Francisco, and ,... + más
COVID-19 in seniors linked to increased Alzheimer’s risk, study finds | Portland Press Herald
About iurex | Privacy Policy | Disclaimer |